Microorganisms in Medicine and Therapeutics

Live attenuated vaccines use weakened pathogens that closely mimic natural infections, triggering robust cellular, humoral, and mucosal immune responses for long-lasting immunity. Inactivated vaccines rely on killed pathogens or subunit components, primarily inducing humoral immunity through antibody production. The choice depends on safety, stability, and desired immune response efficacy.

Recombinant DNA technology enhances vaccine safety by enabling production of pure, non-infectious antigens without live viruses. Yeast-engineered hepatitis B vaccines exemplify this approach, using genetically modified yeast to produce viral surface antigens. This method significantly reduces infection risks while maintaining strong immunogenicity and effective immune recognition.

Beneficial microbes such as Lactobacillus enhance gut health by balancing microbiota and modulating immune responses. These probiotics maintain microbiota balance, prevent gastrointestinal disorders, and enhance overall immune function. Research suggests they may also influence neurological health through the gut-brain axis, offering personalized microbiome-based therapeutic potential.

Viral vectors like adenoviruses and lentiviruses efficiently deliver therapeutic genes into host cells. Lentiviruses integrate genes into the host genome in transcriptionally active regions, ensuring sustained gene expression while minimizing insertional mutagenesis risks. This precise delivery capability enables treatment of genetic disorders including cystic fibrosis, hemophilia, and inherited blindness.

mRNA vaccines instruct host cells to synthesize viral antigens, eliciting immune responses without live pathogens present. The COVID-19 vaccine exemplifies this technology, offering rapid development and scalability for combating emerging infectious diseases. However, challenges such as cold storage requirements and potential transient immunity need addressing for broader applicability.

Penicillin, derived from Penicillium mold, marked a turning point in combating bacterial infections and revolutionized infectious disease treatment. Many modern antibiotics like streptomycin and tetracycline originate from soil bacteria such as Streptomyces species. Continued study of microbial metabolites holds promise for overcoming antibiotic resistance and developing novel therapeutic agents.

The MMR vaccine contains live attenuated forms of measles, mumps, and rubella that mimic natural infections, stimulating both cellular and humoral immunity. This dual immune response provides robust, long-lasting protection against these diseases. The vaccine's ability to trigger multiple immune pathways makes it highly effective at preventing infection.